Back to Search Start Over

Prokinetics-safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review.

Authors :
Bor S
Kalkan İH
Savarino E
Rao S
Tack J
Pasricha J
Cangemi D
Schol J
Karunaratne T
Ghisa M
Ahuja NK
Lacy B
Source :
Neurogastroenterology and motility [Neurogastroenterol Motil] 2024 May; Vol. 36 (5), pp. e14774. Date of Electronic Publication: 2024 Mar 10.
Publication Year :
2024

Abstract

Background: Prokinetics are a class of pharmacological drugs designed to improve gastrointestinal (GI) motility, either regionally or across the whole gut. Each drug has its merits and drawbacks, and based on current evidence as high-quality studies are limited, we have no clear recommendation on one class or other. However, there remains a large unmet need for both regionally selective and/or globally acting prokinetic drugs that work primarily intraluminally and are safe and without systemic side effects.<br />Purpose: Here, we describe the strengths and weaknesses of six classes of prokinetic drugs, including their pharmacokinetic properties, efficacy, safety and tolerability and potential indications.<br /> (© 2024 John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
1365-2982
Volume :
36
Issue :
5
Database :
MEDLINE
Journal :
Neurogastroenterology and motility
Publication Type :
Academic Journal
Accession number :
38462678
Full Text :
https://doi.org/10.1111/nmo.14774